At the recent AACR Special Conference on Breaking Barriers in the Fight Against Rare Cancers, AACR Immediate Past President...
In the midst of Breast Cancer Awareness Month, the US. Food and Drug Administration (FDA) provided good news for...
Breast cancer is the most commonly diagnosed cancer in the United States. In 2018, 266,120 women and 2,550 men...
In a study published in the AACR’s journal Clinical Cancer Research, a team of scientists from the University of...
The 30th Anniversary AACR Special Conference Convergence: Artificial Intelligence, Big Data, and Prediction in Cancer is focusing on a...
On Sunday, Margaret Foti, PhD, MD (hc), chief executive officer of the AACR, met with the president of Israel,...
Last week saw a flurry of new anticancer therapeutics approved by the U.S. Food and Drug Administration (FDA) for...
Acute lymphoblastic leukemia (ALL) is an aggressive cancer of the bone marrow and the blood that develops in either...
On Monday, James P. Allison, PhD, a Fellow of the AACR Academy and a past member of the AACR’s...
Editor’s note: Progress and Promise Against Cancer is the AACR’s initiative to educate the public about cancer and cancer...
As a monthly feature on this blog, we spotlight the 10 articles selected by our editors from each journal...